:: CLDF ::

Home | Contact Us | Bookmark

ALCOHOL LIVER DISEASE

PEDIATRIC LIVER DISEASE

Embassy of Education

Publications Webcasts Abstract Library Committee Members

MASH Single Disease Content

Publications


	CLDF Payer Coalition Practicum on Metabolic Dysfunction-Associated Steatohepatitis

	The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosis

Webcast Library


	Innovations in the Management of MASH Nadege Gunn, MD, CPI, DABOM		Educational Webcast

	Advances in Non-Invasive Assessment and Management of MASLD Rohit Loomba, MD, MHSc		Educational Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from AASLD Nancy Reau, MD, Joseph Ahn, MD & Ann Moore, NP		Accredited Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from ACG Nadege Gunn, MD, CPI, Marcelo Kulgelmas, MD & Christina Hanson, FNP-C		Accredited Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from EASL Kimberly Brown, MD, Sunit Janardhan, MD, PhD & Patrick Horne, MSN, ARNP		Accredited Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from DDW Rohit Loomba, MD, Nadege Gunn, MD, CPI & HoChong Gilles, DNP		Accredited Webcast

	CLDF Conversations: New Therapies in MASH & Comprehensive Care Hosted by Nadege Gunn, MD, with Special Guest Sujit Janardhan, MD, PhD		Educational Webcast

	Metabolic-Associated Steatotic Liver Disease: Positioning New and Emerging Therapies with Nancy Reau, MD, Kimberly Brown, MD, and Steven Flamm, MD.		Educational Webcast

	Key Take Aways-Major Advancements In The Management of MASH with Parvez, Mantry, MD		Educational Webcast

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 IU GI & Hepatology Update Conference		Symposium Vignettes

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 Liver Connect Conference		Symposium Vignettes

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 GALA Dallas Conference		Symposium Vignettes

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 Advancing GI Patient Care Conference		Symposium Vignettes

	Liver Connect 2023		Educational Webcast

	NASH Connect 2023		Educational Webcast

	NAFLD/NASH		Educational Webcast

	Advances in NAFLD/NASH		Educational Webcast

	New Advances in NASH Diagnostics and Prognostics		Educational Webcast

	New Advances in NASH Diagnostics and Prognostics		Educational Webcast

	Pearls and Pitfalls update on emerging therapies in NASH		Educational Webcast

Abstract Library

1.	Non-alcoholic fatty liver disease enhances the beneficial effect of renal denervation on gut microbiota aberrations in rats with heart failure.
	Chen, Fuyan (F);Guo, Zhiqin (Z);Chen, Yufeng (Y);Li, Shun (S);Chen, Pingan (P);

2.	Outcomes and experiences of Indigenous patients in Newfoundland and Labrador's bariatric surgery program: a pilot study.
	Hossain, Intekhab (I);O'Brien, Erin (E);Dogar, Ibrahim (I);Dubinsky, Isser (I);Pace, David (D);Smith, Chris (C);

3.	Chronic kidney disease and increased LAVI as risk factors of new-onset heart failure in atrial fibrillation: A case-control study.
	Muin, Resultanti Irwan (RI);Yamin, Muhammad (M);Wijaya, Ika Prasetya (IP);Harimurti, Kuntjoro (K);Shatri, Hamzah (H);Irawan, Cosphiadi (C);Soewondo, Pradana (P);

4.	The causal role of homocysteine in multiple diseases: a systematic review of Mendelian randomization studies.
	Zhu, Xiuyuan (X);Wei, Jiangnan (J);Li, Jingling (J);Zuo, Shunli (S);Wang, Jiaxian (J);Liu, Ning (N);

5.	High fat diet (HFD) induced hepatic lipogenic metabolism and lipotoxicity via Parkin-dependent mitophagy and Err? signal of Pelteobagrus fulvidraco.
	Yu, Angen (A);Hao, Zhiwei (Z);Wei, Xiaolei (X);Tan, Xiaoying (X);Zito, Ester (E);Zheng, Hua (H);Luo, Zhi (Z);

6.	Investigation of the effects of laparoscopic sleeve gastrectomy and laparoscopic one anastomosis gastric bypass on metabolic syndrome components.
	Mutlu, Vahit (V);Yüksek, Mahmut Arif (MA);Koca, Bülent (B);Özbalc?, Gökhan Selçuk (GS);

7.	Cardiac function and atrial conduction time in morbid obesity: Insights from an echocardiographic case-control study.
	Omidi, Fatemeh (F);Sadeghi, Soheila (S);Nasiri, Mohammad Javad (MJ);Ghaffari, Zeinab (Z);Ghafourian, Kiana (K);Panahi, Masoud Hosain (MH);

8.	Dynamic changes in macrophage populations and resulting alterations in Prostaglandin E sensitivity in mice with diet-induced MASH.
	Vahrenbrink, Madita (M);Coleman, C D (CD);Kuipers, S (S);Lurje, I (I);Hammerich, L (L);Kunkel, D (D);Keye, J (J);Dittrich, S (S);Schjeide, B M (BM);Hiß, R (R);Müller, J (J);Püschel, G P (GP);Henkel, J (J);

9.	Unravelling neutropenic enterocolitis: insights from gut microbiota, and intestinal barrier analyses.
	Kapandji, Natacha (N);Salmona, Maud (M);Lemoine, Anaïs (A);Ulmann, Guillaume (G);Calderaro, Julien (J);Roche, Brigitte (B);Kapel, Nathalie (N);Biard, Lucie (L);Lengline, Etienne (E);Goff, Jérôme Le (JL);Rodriguez, Christophe (C);Thomas, Muriel (M);Zafrani, Lara (L);

10.	Liver metabolomic profiles of sea lamprey (Petromyzon marinus) are influenced by sex and maturation stages.
	Tamrakar, Sonam (S);Huerta, Belinda (B);Chung-Davidson, Yu-Wen (YW);Li, Weiming (W);

11.	Potential diagnostic marker gene set for non-alcoholic steatohepatitis associated hepatocellular carcinoma with lymphocyte infiltration.
	Wang, Xueyun (X);Gao, Mengzhou (M);Zhang, Zexi (Z);Ao, Xiang (X);Luo, An (A);Wen, Zhenguo (Z);Pan, Xingquan (X);Sun, Mengge (M);Wang, Teng (T);Jia, Zhaojun (Z);

12.	Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression.
	Koliaki, Chrysi (C);Dalamaga, Maria (M);Kakounis, Konstantinos (K);Liatis, Stavros (S);

13.	Effects of multi-strain synbiotic supplementation on liver enzymes, insulin resistance, anthropometric, and inflammatory indices in overweight and obese adults with fatty liver and diabetes: a randomized controlled trial.
	Yazdani, Aryan M (AM);Fattahi, Mohammad Reza (MR);Eftekhari, Mohammad Hassan (MH);Ahmadi, Afsane (A);Soveid, Mahmood (M);Zare, Morteza (M);Mohsenpour, Mohammad Ali (MA);

14.	Machine learning for predicting all-cause mortality of metabolic dysfunction-associated fatty liver disease: a longitudinal study based on NHANES.
	Wang, Xueni (X);Chen, Huihui (H);Wang, Luqiao (L);Sun, Wenguang (W);

15.	An evaluation of spraying as a delivery method for human mesenchymal stem cells suspended in low-methyl pectin solutions.
	Nash, Ami (A);Lee, I-Ning (IN);Fox, Graeme (G);Phillips, James (J);White, Lisa J (LJ);Marlow, Maria (M);

16.	Association of biological aging and the prevalence of nonalcoholic fatty liver disease: a population-based study.
	Liu, Gang (G);Mao, Qingsong (Q);Tian, Xinling (X);Zhang, Chenwei (C);Zhang, Yukai (Y);He, Jiarong (J);Kong, Yuzhe (Y);

17.	Autolysosomal Dysfunction in Obesity-induced Metabolic Inflammation and Related Disorders.
	Cheong, Lenny Yi Tong (LYT);Saipuljumri, Eka Norfaishanty (EN);Loi, Gavin Wen Zhao (GWZ);Zeng, Jialiu (J);Lo, Chih Hung (CH);

18.	Association of Metabolic Dysfunction-Associated Steatotic Liver Disease With Sudden Sensorineural Hearing Loss Among Older Adults.
	Kang, Eun Seok (ES);Jang, Seohui (S);Kim, Hye Jun (HJ);Kim, Kyuwoong (K);Sha, Meng (M);Oh, Yun Hwan (YH);Suh, Michelle J (MJ);Jeong, Seogsong (S);

19.	Investigation of the degree of family history of diabetes in different clusters of newly diagnosed type 2 diabetes in Thailand.
	Tangjittipokin, Watip (W);Narkdontri, Tassanee (T);Teerawattanapong, Nipaporn (N);Suthon, Sarocha (S);Nakhonsri, Vorthunju (V);Wasitthankasem, Rujipat (R);Sudtachat, Nirinya (N);Preechasuk, Lukana (L);Lapinee, Varisara (V);Thongtang, Nuntakorn (N);Tongsima, Sissades (S);Plengvidhya, Nattachet (N);

20.	Analysis and study of risk factors related to the progression of non-alcoholic fatty liver disease: A retrospective cohort study.
	Yang, JunRan (J);Zhou, Zhenhua (Z);

21.	Association between glucose intolerance and fatty liver disease in women with previous gestational diabetes mellitus in urban Thailand: a prospective cohort study.
	Phaloprakarn, Chadakarn (C);Sethasine, Supatsri (S);

22.	Combined effect of fasting blood glucose and serum uric acid on nonalcoholic fatty liver disease.
	Hao, Yifan (Y);Li, Xuerui (X);Zhang, Yiting (Y);Zheng, Jun (J);Miao, Yuyang (Y);Tan, Jin (J);Zhang, Qiang (Q);

23.	Multiple machine learning algorithms identify 13 types of cell death-critical genes in large and multiple non-alcoholic steatohepatitis cohorts.
	Jiang, Renao (R);Dai, Longfei (L);Xu, Xinjian (X);Zhang, Zhen (Z);

24.	Geospatial inequalities in women's malnutrition in Pakistan.
	Naz, Lubna (L);Ali, Amjad (A);Yasmin, Sabina (S);Trueha, Kassahun (K);

25.	Mitochondrial dysfunction fuels drug resistance in adult T-cell acute lymphoblastic leukemia.
	Guo, Shanshan (S);Bourova-Flin, Ekaterina (E);Rousseaux, Sophie (S);Chuffart, Florent (F);Peng, Lijun (L);Jing, Duohui (D);Mi, Jian-Qing (JQ);Khochbin, Saadi (S);Wang, Jin (J);

HEPATITIS

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

MASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2025 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

Follow us

Youtube

LiverQ

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.